These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33688252)

  • 1. Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
    Li L; Huang H; Zhu M; Wu J
    Cancer Manag Res; 2021; 13():2095-2104. PubMed ID: 33688252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 7. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.
    Lv Q; Liu Y; Huang H; Zhu M; Wu J; Meng D
    Onco Targets Ther; 2020; 13():5541-5550. PubMed ID: 32606769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
    Yuan Q; Zheng L; Liao Y; Wu G
    World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring a novel four-gene system as a diagnostic and prognostic biomarker for triple-negative breast cancer, using clinical variables.
    Ali F; Iqbal A; Azhar I; Qayyum A; Hassan SA; Hasan MSA; Jawi M; Hassan HM; Al-Emam A; Sajid M
    Comput Biol Chem; 2024 Dec; 113():108247. PubMed ID: 39427606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.
    Ren Y; Deng R; Zhang Q; Li J; Han B; Ye P
    Ann Transl Med; 2020 Dec; 8(24):1637. PubMed ID: 33490149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
    He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
    PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
    Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
    Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses.
    Wang D; Xie D; Meng S; Mi J; Wang H; Li L; Zhang Y; Cui Y
    BMC Cancer; 2024 Sep; 24(1):1217. PubMed ID: 39350059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].
    Wang Y; Wang YS; Hu NB; Teng GS; Zhou Y; Bai J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):804-812. PubMed ID: 35680809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
    Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
    Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
    Zhai X; Yang Z; Liu X; Dong Z; Zhou D
    PeerJ; 2020; 8():e9975. PubMed ID: 33005492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
    Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
    PeerJ; 2020; 8():e10265. PubMed ID: 33240619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.